Rx Pricing Debate Must Be Framed As Trade Issue, Pfizer CEO Says
Executive Summary
The pharmaceutical industry needs to re-cast the global pricing and reimportation debate as a trade issue, Pfizer CEO Henry McKinnell told the Bear Stearns conference in New York City Sept. 8
You may also be interested in...
International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations
U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement
FDA Goes Global: Trade Talks Suggest Drug Prices Are Part Of Mission
FDA's involvement in trade negotiations with Australia is the latest sign that the agency's mission is evolving under Commissioner McClellan toward the once-taboo topic of pharmaceutical prices
International Rx Pricing Debate Plays Out In U.S./Australia Trade Negotiations
U.S. government agencies that purchase pharmaceuticals are understood to be exempt from drug price negotiation transparency requirements in a proposed U.S./Australia trade agreement